|
|
U.S. Osteoporosis Diagnostics MarketsPublished by: Frost & Sullivan Published: Jun. 1, 2001 Table of Contents
AbstractNew Peripheral Technologies Drive Market GrowthAs the baby boomer population ages, there will be an increased need to accurately measure the degenerative loss of bone mass. The introduction of peripheral bone densitometers, which measure bone density at the wrist, heel, fingers, or forearm, will drive market growth, as non-hospital end users prefer these faster, less expensive, portable devices to axial equipment, which measures bone density at the hip and spine. Because peripheral technologies are suited for non-hospital use, participants could discover new opportunities in preventive care sectors. This Frost & Sullivan research analyzes the markets for both axial and peripheral densitometers, including subsegments for equipment with specific scanning capabilities. It evaluates drivers and restraints, identifies areas with growth potential, and provides expert forecasts. With such a comprehensive guide to the industry, your company will be poised to optimize its resources and enhance its bottom line. Creating Awareness for New Products is a Top Priority "Technological innovations and improvements have surfaced that will expand the market's offerings substantially," says the study's author. "Nevertheless, positioning these new products remains an obstacle for many manufacturers." Without a solid promotional program, new devices often remain unknown to healthcare institutions, and penetration is substantially diminished. Manufacturers must educate not only hospitals and outpatient care facilities about new technologies, but also the public about the importance of osteoporosis screening. This research highlights emerging industry challenges, enabling your firm to anticipate and overcome hurdles that may lie ahead. Forging Alliances and Expanding Target Markets Should Be High Priorities "To simultaneously advocate the benefits of early screening and promote the availability of drugs without side effects, alliances must be formed between diagnostics manufacturers and pharmaceutical companies," says the author. Drug companies have a vested interest in promoting early screening and diagnosis, with the resources to mount massive marketing campaigns.
Meanwhile, densitometer manufacturers should focus their educational efforts
on new healthcare sites, including primary care facilities, pharmacies, and
other wellness centers or specialty clinics. Companies can also find new
revenue sources by creating awareness in younger populations. This study
offers strategic recommendations, helping its users formulate a plan to
optimize market dominance.
|
|
|||
|
About MarketResearch.com
|
||||